Clin2
NCT07214207Possibly a fitRecruiting

Testing a sleep medicine for alcohol use disorder and stress-related drinking

Alcohol Use Disorder

Treatments studied

Part of Mental health clinical trials.

This trial tests whether a medicine called suvorexant, which is used for sleep, can help people with alcohol use disorder drink less, especially when stressed. You would receive the medicine or a placebo, and researchers will track your drinking and stress levels over several weeks.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
250 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You have a diagnosis of moderate to severe alcohol use disorder.
  • You drink at least 7 drinks per week (women) or 14 drinks per week (men).
  • You are looking for treatment for your drinking.
  • You are generally healthy and not taking certain medications for sleep, liver problems, or other conditions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06326684Recruiting· Early Phase 1
Testing suvorexant for alcohol use disorder

This study tests whether the sleep medication suvorexant can help people with alcohol use disorder drink less. It involves a short stay where you'll receive either suvorexant or a placebo and then have alcohol.

Lexington, Kentucky
NCT05684094Recruiting
Study links sleep, stress, and brain reward in risky drinking

This study looks at how sleep timing and stress affect brain responses related to reward and stress in young adults who drink heavily. It may help researchers understand why some people take bigger alcohol risks and how sleep and stress could be part of safer treatment.

Eugene, Oregon
NCT07532252Not yet recruiting· Phase 2
Daridorexant for Alcohol Use Disorder and Sleep Problems

This study tests whether a medication called daridorexant can help people with alcohol use disorder who also have trouble sleeping. The drug works by helping you fall asleep and stay asleep, which may reduce cravings to drink.

NCT07701928Not yet recruiting· Phase 2
Daridorexant for sleep and alcohol use disorder

This trial tests if the sleep medication daridorexant can help people who have both insomnia and alcohol use disorder. It looks at whether the drug improves sleep and reduces drinking.

Spokane, Washington
NCT03827460Recruiting· Phase 1
Study tests how men and women respond to alcohol abstinence

This Phase 1 study looks at sex differences in how the body and brain respond when people stop drinking alcohol for a short time. You may be asked to complete questionnaires and provide blood samples to measure changes during the abstinence period.

Indianapolis, Indiana
NCT07612631Recruiting· Early Phase 1
Brain imaging study of alcohol and stress response

This research uses brain imaging to understand how two brain systems—one involved in stress and one involved in reward—interact in people with alcohol use disorder. The goal is to find new ways to help people reduce heavy drinking.

Pittsburgh, Pennsylvania

Hear when a new Alcohol Use Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.